Both BIOPOL and DNAREPAIRMAN involve nanoscale biological measurements where AFM instrumentation is a standard enabling technology, and JPK appeared in both as a contributing industrial partner.
JPK INSTRUMENTS AG
Berlin AFM manufacturer contributing nanoscale force and imaging instruments to European biophysics and molecular biology training networks.
Their core work
JPK Instruments AG is a Berlin-based manufacturer of precision nanoscale measurement instruments, best known for atomic force microscopes (AFM) and related force-sensing tools widely used in biophysics, cell biology, and materials science. In their H2020 engagements, they participated as an industrial partner in two Marie Skłodowska-Curie Innovative Training Networks, contributing specialized instrumentation, technical training environments, and research infrastructure to doctoral programs. Their involvement in projects studying mechanochemical forces in living cells and molecular machinery for DNA repair reflects the core application domains for their equipment. They function as a science-enabling company: their instruments make it possible to observe and measure the forces, structures, and dynamics underlying fundamental biological processes at the nanoscale.
What they specialise in
BIOPOL (2015-2018) focused on biochemical and mechanochemical mechanisms in polarized cells, a domain where AFM force spectroscopy is a primary measurement tool.
DNAREPAIRMAN (2017-2020) examined molecular machines for DNA repair, where high-resolution force and imaging instruments are used to study protein-DNA interactions at the single-molecule level.
Both projects were MSCA-ITN-ETN training networks in which JPK participated as an industrial partner, hosting and co-training doctoral researchers alongside academic consortia.
How they've shifted over time
JPK Instruments' H2020 participation spans two projects, both within MSCA training networks in biophysics and molecular biology between 2015 and 2020. No keyword data is available from CORDIS to support a granular shift analysis, but the project titles suggest a slight extension from cell-level mechanobiology (BIOPOL) toward molecular machine and DNA-scale structural biology (DNAREPAIRMAN). With only two data points, this trend should be read as directional rather than definitive.
JPK appears to be extending their presence from cellular force measurements toward single-molecule and sub-molecular structural biology, consistent with the broader AFM market moving into DNA and protein-level analysis.
How they like to work
JPK Instruments participates exclusively as a partner or third party in EU projects, never as a coordinator — a pattern typical of instrument manufacturers who contribute equipment access, technical training, and research infrastructure rather than project administration. With 26 unique partners across 8 countries from just two projects, they are embedded in broad MSCA training consortia that draw on many academic and industrial nodes. This signals they are well-networked across European biophysics without seeking leadership roles, making them a pragmatic and low-friction partner to bring into a consortium.
JPK has engaged with 26 unique consortium partners across 8 countries through only two projects, a high ratio that reflects the large multi-node structure of MSCA-ITN networks. Their geographic footprint is genuinely European, with no apparent concentration in a single country.
What sets them apart
JPK Instruments occupies a rare position as a specialist scientific instrument manufacturer that integrates directly into EU research training ecosystems rather than stopping at equipment sales. By hosting doctoral researchers and contributing methodological expertise within MSCA networks, they become embedded in the research community rather than remaining a vendor at arm's length. For consortium builders, this means JPK brings both precision instrumentation and a credible track record of collaborative research training — a combination that strengthens both the scientific capacity and the industrial relevance of any proposal.
Highlights from their portfolio
- BIOPOLJPK's only directly funded H2020 project (EUR 249,216), focused on mechanochemical mechanisms in polarized cells — a direct application domain for their core AFM force spectroscopy business.
- DNAREPAIRMANExtended JPK's consortium network into the molecular machine and DNA repair research community, broadening their academic footprint beyond cell biophysics into structural molecular biology.